Ovison (Mometasone Furoate)

Mometasone furoate, the active ingredient in Ovison, is a corticosteroid presented as a topical formulation for dermatological use. It treats inflammatory skin conditions such as eczema, psoriasis and allergic dermatitis in adults and children. GNH USA supplies Ovison as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Ovison as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone furoate is a potent topical corticosteroid that acts on inflammatory skin pathways.

- Eczema: Reduces redness, itching and swelling associated with atopic dermatitis. - Psoriasis: Helps to control plaque formation and skin scaling. - Allergic dermatitis: Alleviates irritation and inflammation caused by contact allergens. - Seborrheic dermatitis: Decreases flaking and erythema on the scalp and face. - Lichen planus: Mitigates lesions and discomfort on mucosal surfaces.

Mometasone furoate may elicit a range of skin‑related adverse reactions.

Common Side Effects: - Burning sensation - Itching - Dry skin - Folliculitis - Skin thinning (atrophy) - Telangiectasia

Serious or Rare Side Effects: - Secondary infection : t  t  t  t. -  t      t           ...  """"  ""  """ "" """ "" … … " … " … … … ""